Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, Q1, 2011

Date: January 1, 2011
Pages: 24
Price:
US$ 1,000.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AEB87664AAFEN
Leaflet:

Download PDF Leaflet

Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, Q1, 2011
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, Q1, 2011' provides data on the Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope
  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute, and others

Reasons to buy
  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy
Subjects Recruited Over a Period of Time
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Top Universities / Institutes / Hospitals
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Fred Hutchinson Cancer Research Center-Technology Transfer
Clinical Trial Overview of Fred Hutchinson Cancer Research Center-Technology Transfer
Appendix
Abbreviations
AILT: Angioimmunoblastic T-cell Lymphoma
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source 23

LIST OF TABLES

Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Market, Global, Clinical Trials by Zone, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Clinical Trials, North America, Top Countries, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Market, Global, Clinical Trials by Phase, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Market, Global, Terminated Clinical Trials, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center-Technology Transfer, 2011* 20

LIST OF FIGURES

Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011*
GlobalData Methodology 22

Ask Your Question

Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, Q1, 2011
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: